This event is not part of the official Scientific Sessions 2018 as planned by the AHA Committee on Scientific Sessions Programming
Registration for this program is now closed.
Faculty: Pamela Morris, MD (Chair); Christie Ballantyne, MD; Robert Giugliano, MD, SM; Peter Jones, MD; James Underberg, MD, MS
Program Overview:
In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.
Educational Objectives:
Upon completion of this program, attendees should be able to:
Identify statin-benefit groups and explain the importance of using highintensity
statin therapy in appropriate patients.
Discuss the relationship between achieved LDL-C, major cardiovascular
outcomes, and safety at very low LDL-C levels.
Interpret the evidence from cardiovascular outcome trials with PCSK9
inhibitors and ezetimibe.
Recognize primary and secondary prevention patient populations for
consideration of non-statin therapy.
Indicate guideline recommendations for lowering LDL-C and reducing
cardiovascular risk.
Target Audience:
This educational activity is intended for cardiovascular clinicians.
Accreditation & Credit Designation:
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia LLC designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 CreditsTM through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.
Educational Grant:
Voxmedia International gratefully acknowledges the educational donation provided by Amgen.